R1317

Pharmaceutical compound From Wikipedia, the free encyclopedia

R1317 is a desmethylprodine analog in which the N-methyl group is replaced by a cinnamyl group. This change in sidechain endows the compound with an increase in potency. The compound is 261 times more potent[clarification needed] than meperidine in mice[1] and 1100 times more potent in rats. In another article it was stated to be 785 times more potent than meperidine.[2]

Other names1-Cinnamyl-4-phenyl-4-piperidinol propionate
CAS Number
Quick facts Clinical data, Other names ...
R1317
Clinical data
Other names1-Cinnamyl-4-phenyl-4-piperidinol propionate
Identifiers
  • [4-phenyl-1-[(E)-3-phenylprop-2-enyl]piperidin-4-yl] propanoate
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC23H27NO2
Molar mass349.474 g·mol−1
3D model (JSmol)
  • CCC(=O)OC1(CCN(CC1)C/C=C/C2=CC=CC=C2)C3=CC=CC=C3
  • InChI=1S/C23H27NO2/c1-2-22(25)26-23(21-13-7-4-8-14-21)15-18-24(19-16-23)17-9-12-20-10-5-3-6-11-20/h3-14H,2,15-19H2,1H3/b12-9+
  • Key:STWAFYHWLNRRHY-FMIVXFBMSA-N
Close

Despite this high potency, it is not the most potent 4-phenylpiperidine-reverse ester ever created. The most potent 4-phenylpiperidine-reverse ester ever created is R1480.[1] R1480 is stated to have a potency 1500-3180 times higher than meperidine in mice and 3040 times higher in rats.

R1480

References

Related Articles

Wikiwand AI